Vimarsana
Biggest News Aggregation in the World

Page 2 - Model Lists News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Model Lists. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Model Lists Today - Breaking & Trending Today

WHO Publishes Model Lists Of Essential Medicines - Vimarsana News

WHO Publishes Model Lists Of Essential Medicines

The World Health Organization has published the new editions of the Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc). The latest update includes important new medicines for the treatment of multiple sclerosis, cancer, infectious diseases, and cardiovascular conditions, among others.

WHO publishes new essential medicines; sweeping impact seen - Vimarsana News

WHO publishes new essential medicines; sweeping impact seen

The World Health Organization (WHO) has published the Model Lists of Essential Medicines (EML) which could have a very large public health impact globally without jeopardising the health budgets of low- and middle-income countries.

For The First Time, Medicines For Multiple Sclerosis Added To WHO Essential Medicines List - Vimarsana News

For The First Time, Medicines For Multiple Sclerosis Added To WHO Essential Medicines List

The World Health Organization (WHO) has updated the Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc), by adding many innovative medicines. TheHealthSite.com

WHO updates list of essential medicines to include heart 'polypills,' MS treatments but not weight-loss drugs - Vimarsana News

WHO updates list of essential medicines to include heart 'polypills,' MS treatments but not weight-loss drugs

The World Health Organization updated its guidelines for essential medicines Wednesday to include drugs to treat multiple sclerosis, heart conditions, cancer and more. But obesity medications were not added to the list, despite requests this year from researchers in the United States.

Source: cnn.com
MPP signs licence agreement to increase access to nilotinib for the treatment of chronic myeloid leukaemia - Vimarsana News

MPP signs licence agreement to increase access to nilotinib for the treatment of chronic myeloid leukaemia

MPP signs licence agreement to increase access to nilotinib for the treatment of chronic myeloid leukaemia20 October 2022This is the first ever public health-oriented voluntary licence agreementon a cancer medicineGeneva – On the side lines of the World Cancer Congress, the Medicines Patent Pool (MPP) tod...